Shire (pharmaceutical company)
Shire Pharmaceuticals Group plc is a British manufacturer of pharmaceuticals including Adderall XR, Carbatrol, and Fosrenol. Founded in 1986, Shire had revenues for the full year 2004 of $1,363.2 million and an operating income of $446.4 million. The growth rates for revenues were 13% for 2004 over the prior year.
Corporate Strategy
Shire’s strategic goal is to become the leading specialty pharmaceutical company that focuses on meeting the needs of the specialist physician. Shire focuses its business on central nervous system (CNS), gastrointestinal (GI), general products (GP) and human genetic therapies (HGT), all being areas in which Shire has a commercial presence. The structure is sufficiently flexible to allow Shire to target new therapeutic areas to the extent opportunities arise through acquisitions. Shire believes that a carefully selected portfolio of products with a strategically aligned and relatively small-scale sales force will deliver strong results. Shire’s focused strategy is to develop and market products for specialty physicians. This approach aims to deliver increased returns and lower risks. Shire’s in-licensing and merger and acquisition efforts are focused on products in niche markets with strong intellectual property protection either in the U.S. or Europe.
Corporate Leadership
Matthew Emmens is the Chief Executive Officer and Chairman of the Executive Committee. The non-executive Board Chairman is Dr. James Cavanaugh.
Financial Information
Shire is traded on three stock exchanges:
1. The London Stock Exchange, where its symbol is SHP.L. Shire is a constituent of the FTSE 100 Index.
2. The NASDAQ, where its symbol is SHPGY.
3. The Toronto Stock Exchange, where its symbol is SHQ.TO.
Locations
The corporate offices are located in Basingstoke, Hampshire. The address is:
Hampshire International Business Park
Chineham Basingstoke
Hampshire
RG24 8EP
United Kingdom
Other major offices are located in the United States in Wayne, Pennsylvania and Cambridge, Massachusetts. Shire also owns a manufacturing site in Owings Mills, Maryland.